Northstar Insights

Each week, Catalyst 3 picks one published article that matters to the people who run oncology practices. That includes practice administrators, Oncologists, infusion nurse managers and revenue cycle teams. We summarize the article in our own words, link to the original, and then write our response.

Our response covers what the findings could mean for daily operations in a community oncology setting. We look at infusion chair capacity, nurse staffing, scheduling, drug administration documentation, Medicare Part B rules, prior authorization and claim follow-up. When a study comes from outside the United States, we say so and point out where U.S. payer rules or drug labeling could change the picture.

Where we can, we suggest practical questions for your team to discuss. We try to separate what a study measured from what it suggests. We never add numbers the authors didn't report.

We read the journals and practice publications on our Oncology News page and choose articles with a clear connection to how cancer care is delivered, documented or paid for. Clinical treatment questions belong to Oncologists and their patients, so our responses focus on operations, workflow and revenue. Nothing here is medical advice.

Every post names the authors, the journal and the publication date, with a DOI or PubMed link. Article text belongs to its publisher, so we summarize instead of copying. You can follow new posts with our RSS feed.

Have an article you want us to cover, or a different take on one of ours? Call (307) 301-4304 or email innovate@thecatalyst3.com.